{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T07:00:34Z","timestamp":1775545234269,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T00:00:00Z","timestamp":1512345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T00:00:00Z","timestamp":1512345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Injection of amniotic fluid stem cells (AFSC) delays the course of progression of renal fibrosis in animals with Alport Syndrome, enhancing kidney function and improving survival. The mechanisms responsible for these protective outcomes are still largely unknown. Here, we showed that vascular endothelial growth factor (VEGF) signaling within the glomeruli of Alport mice is strongly elevated early on in the disease, causing glomerular endothelial cell damage. Intraventricular injected AFSC that homed within the glomeruli showed strong modulation of the VEGF activity, particularly in glomerular endothelial cells. To investigate this phenomenon we hypothesized that extracellular vesicles (EVs) produced by the AFSC could be responsible for the observed renoprotection. AFSC derived EVs presented exosomal and stem cell markers on their surface membrane, including VEGFR1 and VEGFR2. EVs were able to modulate VEGF in glomerular endothelial cells by effectively trapping the excess VEGF through VEGFR1-binding preventing cellular damage. In contrast, VEGFR1\/sVEGFR1 knockout EVs failed to show similar protection, thus indicating that VEGF trapping is a potentially viable mechanism for AFSC-EV mediated renoprotection. Taken together, our findings establish that EVs secreted by AFSC could target a specific signaling pathway within the glomerulus, thus representing a new potential glomerulus-specific targeted intervention.<\/jats:p>","DOI":"10.1038\/s41598-017-17061-2","type":"journal-article","created":{"date-parts":[[2017,11,28]],"date-time":"2017-11-28T12:42:37Z","timestamp":1511872957000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Amniotic fluid stem cell-derived vesicles protect from VEGF-induced endothelial damage"],"prefix":"10.1038","volume":"7","author":[{"given":"S.","family":"Sedrakyan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Villani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Da Sacco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Tripuraneni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Porta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Achena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lavarreda-Pearce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Petrosyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Soloyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. E. De","family":"Filippo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Bussolati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Perin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,4]]},"reference":[{"key":"17061_CR1","first-page":"231","volume":"24","author":"H Dimke","year":"2015","unstructured":"Dimke, H., Maezawa, Y. & Quaggin, S. E. Crosstalk in glomerular injury and repair. Curr Opin Nephrol Hypertens \n                           24, 231\u2013238 (2015).","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"17061_CR2","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.biocel.2010.05.015","volume":"42","author":"AB Fogo","year":"2010","unstructured":"Fogo, A. B. & Kon, V. The glomerulus\u2013a view from the inside\u2013the endothelial cell. Int J Biochem Cell Biol \n                           42, 1388\u20131397 (2010).","journal-title":"Int J Biochem Cell Biol"},{"key":"17061_CR3","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.biocel.2010.05.014","volume":"42","author":"H Cheng","year":"2010","unstructured":"Cheng, H. & Harris, R. C. The glomerulus\u2013a view from the outside\u2013the podocyte. Int J Biochem Cell Biol \n                           42, 1380\u20131387 (2010).","journal-title":"Int J Biochem Cell Biol"},{"key":"17061_CR4","doi-asserted-by":"publisher","first-page":"p32","DOI":"10.1159\/000101798","volume":"106","author":"V Eremina","year":"2007","unstructured":"Eremina, V., Baelde, H. J. & Quaggin, S. E. Role of the VEGF\u2013a signaling pathway in the glomerulus: evidence for crosstalk between components of the glomerular filtration barrier. Nephron Physiol \n                           106, p32\u201337 (2007).","journal-title":"Nephron Physiol"},{"key":"17061_CR5","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1146\/annurev-physiol-021115-105412","volume":"78","author":"CS Bartlett","year":"2016","unstructured":"Bartlett, C. S., Jeansson, M. & Quaggin, S. E. Vascular Growth Factors and Glomerular Disease. Annu Rev Physiol \n                           78, 437\u2013461 (2016).","journal-title":"Annu Rev Physiol"},{"key":"17061_CR6","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1172\/JCI17423","volume":"111","author":"V Eremina","year":"2003","unstructured":"Eremina, V. et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest \n                           111, 707\u2013716 (2003).","journal-title":"J Clin Invest"},{"key":"17061_CR7","doi-asserted-by":"publisher","first-page":"e101779","DOI":"10.1371\/journal.pone.0101779","volume":"9","author":"YL Zhai","year":"2014","unstructured":"Zhai, Y. L. et al. Elevated soluble VEGF receptor sFlt-1 correlates with endothelial injury in IgA nephropathy. PLoS One \n                           9, e101779 (2014).","journal-title":"PLoS One"},{"key":"17061_CR8","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1172\/JCI17189","volume":"111","author":"SE Maynard","year":"2003","unstructured":"Maynard, S. E. et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest \n                           111, 649\u2013658 (2003).","journal-title":"J Clin Invest"},{"key":"17061_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1523-1755.2005.00067.x","volume":"67","author":"NH Kim","year":"2005","unstructured":"Kim, N. H. et al. Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy. Kidney Int \n                           67, 167\u2013177 (2005).","journal-title":"Kidney Int"},{"key":"17061_CR10","doi-asserted-by":"crossref","unstructured":"Bai X, Li X, Tian J, Zhou Z. Antiangiogenic treatment diminishes renal injury and dysfunction via regulation of local AKT in early experimental diabetes. PLoS One, e96117 (2014).","DOI":"10.1371\/journal.pone.0096117"},{"key":"17061_CR11","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/ndt\/gfi217","volume":"21","author":"BF Schrijvers","year":"2006","unstructured":"Schrijvers, B. F., Flyvbjerg, A., Tilton, R. G., Lameire, N. H. & De Vriese, A. S. A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat. Nephrol Dial Transplant. \n                           21, 324\u20139 (2006).","journal-title":"Nephrol Dial Transplant."},{"key":"17061_CR12","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1681\/ASN.2011030243","volume":"23","author":"S Sedrakyan","year":"2012","unstructured":"Sedrakyan, S. et al. Injection of Amniotic Fluid Stem Cells Delays Progression of Renal Fibrosis. Journal of the American Society of Nephrology \n                           23, 661\u2013673 (2012).","journal-title":"Journal of the American Society of Nephrology"},{"key":"17061_CR13","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/ki.2010.278","volume":"78","author":"G Camussi","year":"2010","unstructured":"Camussi, G., Deregibus, M. C., Bruno, S., Cantaluppi, V. & Biancone, L. Exosomes\/microvesicles as a mechanism of cell-to-cell communication. Kidney Int \n                           78, 838\u2013848 (2010).","journal-title":"Kidney Int"},{"key":"17061_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1089\/ten.teb.2014.0300","volume":"21","author":"TN Lamichhane","year":"2015","unstructured":"Lamichhane, T. N. et al. Emerging roles for extracellular vesicles in tissue engineering and regenerative medicine. Tissue Eng Part B Rev \n                           21, 45\u201354 (2015).","journal-title":"Tissue Eng Part B Rev"},{"key":"17061_CR15","doi-asserted-by":"publisher","first-page":"1073140","DOI":"10.1155\/2016\/1073140","volume":"2016","author":"M Nawaz","year":"2016","unstructured":"Nawaz, M. et al. Extracellular Vesicles: Evolving Factors in Stem Cell Biology. Stem Cells Int \n                           2016, 1073140 (2016).","journal-title":"Stem Cells Int"},{"key":"17061_CR16","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00418-012-0987-3","volume":"138","author":"L Herrnberger","year":"2012","unstructured":"Herrnberger, L. et al. Lack of endothelial diaphragms in fenestrae and caveolae of mutant Plvap-deficient mice. Histochem Cell Biol. \n                           138, 709\u201324 (2012).","journal-title":"Histochem Cell Biol."},{"key":"17061_CR17","doi-asserted-by":"publisher","first-page":"F947","DOI":"10.1152\/ajprenal.90601.2008","volume":"296","author":"SC Satchell","year":"2009","unstructured":"Satchell, S. C. & Braet, F. Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier. Am J Physiol Renal Physiol. \n                           296, F947\u201356 (2009).","journal-title":"Am J Physiol Renal Physiol."},{"key":"17061_CR18","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1681\/ASN.2007010119","volume":"18","author":"A Singh","year":"2007","unstructured":"Singh, A. et al. Glomerular endothelial glycocalyx constitutes a barrier to protein permeability. J Am Soc Nephrol. \n                           18, 2885\u201393 (2007).","journal-title":"J Am Soc Nephrol."},{"key":"17061_CR19","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/path.3964","volume":"226","author":"AH Salmon","year":"2012","unstructured":"Salmon, A. H. & Satchell, S. C. Endothelial glycocalyx dysfunction in disease: albuminuria and increased microvascular permeability. J Pathol. \n                           226, 562\u201374 (2012).","journal-title":"J Pathol."},{"key":"17061_CR20","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/sj.ki.5002486","volume":"72","author":"S Keller","year":"2007","unstructured":"Keller, S. et al. CD24 is a marker of exosomes secreted into urine and amniotic fluid. Kidney Int \n                           72, 1095\u20131102 (2007).","journal-title":"Kidney Int"},{"key":"17061_CR21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1161\/ATVBAHA.112.300142","volume":"33","author":"LT Dang","year":"2013","unstructured":"Dang, L. T., Lawson, N. D. & Fish, J. E. MicroRNA control of vascular endothelial growth factor signaling output during vascular development. Arterioscler Thromb Vasc Biol \n                           33, 193\u2013200 (2013).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"17061_CR22","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1007\/s00467-007-0524-0","volume":"22","author":"AB Fogo","year":"2007","unstructured":"Fogo, A. B. Mechanisms of progression of chronic kidney disease. Pediatr Nephrol \n                           22, 2011\u20132022 (2007).","journal-title":"Pediatr Nephrol"},{"key":"17061_CR23","doi-asserted-by":"publisher","first-page":"12605","DOI":"10.1074\/jbc.C300012200","volume":"278","author":"H Sugimoto","year":"2003","unstructured":"Sugimoto, H. et al. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem \n                           278, 12605\u201312608 (2003).","journal-title":"J Biol Chem"},{"key":"17061_CR24","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1681\/ASN.2006010064","volume":"17","author":"SH Sung","year":"2006","unstructured":"Sung, S. H. et al. Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice. J Am Soc Nephrol \n                           17, 3093\u20133104 (2006).","journal-title":"J Am Soc Nephrol"},{"key":"17061_CR25","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1097\/00007890-199903270-00024","volume":"67","author":"HL Pilmore","year":"1999","unstructured":"Pilmore, H. L., Eris, J. M., Painter, D. M., Bishop, G. A. & McCaughan, G. W. Vascular endothelial growth factor expression in human chronic renal allograft rejection. Transplantation. \n                           67, 929\u201333 (1999).","journal-title":"Transplantation."},{"key":"17061_CR26","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1136\/jcp.52.10.735","volume":"52","author":"E Bailey","year":"1999","unstructured":"Bailey, E. et al. Vascular endothelial growth factor mRNA expression in minimal change, membranous, and diabetic nephropathy demonstrated by non-isotopic in situ hybridisation. Journal of Clinical Pathology. \n                           52, 735\u2013738 (1999).","journal-title":"Journal of Clinical Pathology."},{"key":"17061_CR27","doi-asserted-by":"publisher","first-page":"e0135648","DOI":"10.1371\/journal.pone.0135648","volume":"10","author":"H Wang","year":"2015","unstructured":"Wang, H. et al. The Accumulation of VEGFA in the Glomerular Basement Membrane and Its Relationship with Podocyte Injury and Proteinuria in Alport Syndrome. PLoS One \n                           10, e0135648 (2015).","journal-title":"PLoS One"},{"key":"17061_CR28","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.cell.2012.08.037","volume":"151","author":"J Jin","year":"2012","unstructured":"Jin, J. et al. Soluble FLT1 binds lipid microdomains in podocytes to control cell morphology and glomerular barrier function. Cell \n                           151, 384\u2013399 (2012).","journal-title":"Cell"},{"key":"17061_CR29","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nrneph.2012.259","volume":"9","author":"J Kruegel","year":"2013","unstructured":"Kruegel, J., Rubel, D. & Gross, O. Alport syndrome\u2013insights from basic and clinical research. Nat Rev Nephrol \n                           9, 170\u2013178 (2013).","journal-title":"Nat Rev Nephrol"},{"key":"17061_CR30","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1161\/CIRCRESAHA.111.253286","volume":"109","author":"S Sahoo","year":"2011","unstructured":"Sahoo, S. et al. Exosomes from human CD34(+) stem cells mediate their proangiogenic paracrine activity. Circ Res \n                           109, 724\u2013728 (2011).","journal-title":"Circ Res"},{"key":"17061_CR31","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejphar.2016.06.058","volume":"790","author":"S Bruno","year":"2016","unstructured":"Bruno, S., Porta, S. & Bussolati, B. Extracellular vesicles in renal tissue damage and regeneration. Eur J Pharmacol \n                           790, 83\u201392 (2016).","journal-title":"Eur J Pharmacol"},{"key":"17061_CR32","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1093\/ndt\/gfr015","volume":"26","author":"S Gatti","year":"2011","unstructured":"Gatti, S. et al. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol Dial Transplant \n                           26, 1474\u20131483 (2011).","journal-title":"Nephrol Dial Transplant"},{"key":"17061_CR33","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1681\/ASN.2008070798","volume":"20","author":"S Bruno","year":"2009","unstructured":"Bruno, S. et al. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol \n                           20, 1053\u20131067 (2009).","journal-title":"J Am Soc Nephrol"},{"key":"17061_CR34","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/kisup.2011.21","volume":"1","author":"B Imberti","year":"2011","unstructured":"Imberti, B., Morigi, M. & Benigni, A. Potential of mesenchymal stem cells in the repair of tubular injury. Kidney Int Suppl (2011) \n                           1, 90\u201393 (2011).","journal-title":"Kidney Int Suppl (2011)"},{"key":"17061_CR35","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1177\/1947601911423031","volume":"2","author":"M Shibuya","year":"2011","unstructured":"Shibuya, M. Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis: A Crucial Target for Anti- and Pro-Angiogenic Therapies. Genes Cancer \n                           2, 1097\u20131105 (2011).","journal-title":"Genes Cancer"},{"key":"17061_CR36","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1002\/sctm.16-0297","volume":"5","author":"C Balbi","year":"2017","unstructured":"Balbi, C. et al. First Characterization of Human Amniotic Fluid Stem Cell Extracellular Vesicles as a Powerful Paracrine Tool Endowed with Regenerative Potential. Stem Cells Transl Med. \n                           5, 1340\u20131355 (2017).","journal-title":"Stem Cells Transl Med."},{"key":"17061_CR37","doi-asserted-by":"publisher","first-page":"e42840","DOI":"10.1371\/journal.pone.0042840","volume":"7","author":"DM Iglesias","year":"2012","unstructured":"Iglesias, D. M. et al. Stem cell microvesicles transfer cystinosin to human cystinotic cells and reduce cystine accumulation in vitro. PLoS One \n                           7, e42840 (2012).","journal-title":"PLoS One"},{"key":"17061_CR38","doi-asserted-by":"publisher","first-page":"e0159163","DOI":"10.1371\/journal.pone.0159163","volume":"11","author":"G Chiabotto","year":"2016","unstructured":"Chiabotto, G., Bruno, S., Collino, F. & Camussi, G. Mesenchymal Stromal Cells Epithelial Transition Induced by Renal Tubular Cells-Derived Extracellular Vesicles. PLoS One \n                           11, e0159163 (2016).","journal-title":"PLoS One"},{"key":"17061_CR39","doi-asserted-by":"publisher","first-page":"e81812","DOI":"10.1371\/journal.pone.0081812","volume":"8","author":"S Da Sacco","year":"2013","unstructured":"Da Sacco, S. et al. A novel source of cultured podocytes. PLoS One \n                           8, e81812 (2013).","journal-title":"PLoS One"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-17061-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-17061-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-17061-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T14:57:05Z","timestamp":1671807425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-17061-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,4]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["17061"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-17061-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,4]]},"assertion":[{"value":"19 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"16875"}}